Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
AstraZeneca and Gilead have won approval for treatments of an advanced form of the disease.
The US Food and Drug Administration (FDA) has approved two of Merck & Co's (MSD) Keytruda (pembrolizumab) and Keytruda Qlex ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug ...
The US FDA has sought Indian pharma's help for the cancer drug ifosfamide, while India works to fix its own cisplatin and carboplatin shortage. Here's what is driving both.
Jaguar's recently completed pivotal effectiveness study of crofelemer for the treatment of CID in dogs demonstrates ...
The fight against deadly pancreatic cancer took a positive turn this spring with a study finding a new drug can help patients ...
Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...
Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a ...
The Food and Drug Administration approved a combination treatment by Merck & Co., Pfizer, and Astellas Pharma for a hard-to-treat form of bladder cancer. The agency greenlit Merck's Keytruda and its ...
Sunvozertinib lung cancer treatment hit a milestone as AstraZeneca paid $600M upfront for Zegfrovy, the first oral pill to ...
Worm infestations are among the most common parasitic infections in the world, with a disproportionate burden of infection in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results